evenfolioETF Details
Tema ETFs·Health·CANC · Nasdaq
Tema Oncology ETF (CANC)
- Price
- $42.29
- —30 Oct 2026
- Assets
- $208.6M
- Total net assets
- Expense ratio
- 0.75%
- Category 1.00%
- Yield
- 0.05%
- Trailing distributions
- 1Y return
- 37.7%+8.9%
- Category 28.8%
- 3Y CAGR
- 26.8%+5.3%
- Category 21.5%
- 5Y CAGR
- —
- Category 4.1%
Loading NAV history…
Tema Oncology ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | +0.7% | +4.2% | +13.9% | +21.8% | +37.7% | +26.8% | — | — | +116.9% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | -2.9% | -5.7% | -9.2% | +1.4% | +8.9% | +5.3% | — | — | +105.3% |
Holdings
The 10 largest positions make up 39.9% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| RVMD | Revolution Medicines Inc Ordinary Shares | 5.48% |
| MRK | Merck & Co Inc | 4.84% |
| COGT | Cogent Biosciences Inc | 4.72% |
| LLY | Eli Lilly and Co | 4.55% |
| NOVN.SW | Novartis AG Registered Shares | 3.68% |
| BMY | Bristol-Myers Squibb Co | 3.45% |
| ONC | BeOne Medicines Ltd ADR | 3.34% |
| IOVA | Iovance Biotherapeutics Inc | 3.32% |
| ABBV | AbbVie Inc | 3.30% |
| GMAB | Genmab AS ADR | 3.20% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- —
- P/B
- 6.5
- P/S
- 7.0
- P/CF
- —
Sector allocation
Share of the equity the fund holds.
- Health care100.0%
Asset mix
- Stocks99.4%
- Cash0.6%
ETF details
- Issuer
- Tema ETFs
- Category
- Equity · Health
- Ticker
- CANC
- Exchange
- Nasdaq
- Inception
- 14 Aug 2023 (3.2 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.75% (category 1.00%)
- Holdings turnover
- 68% (category 51%)
- Distribution yield
- 0.05%
- Beta, 3 years
- 0.73
- Total net assets
- $208.6M
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- XHE · State Street SPDR S&P Health Care Equipment ETFState Street Investment Management · $185.7M · ER 0.35%5Y -6.2%
- PSCH · Invesco S&P SmallCap Health Care ETFInvesco · $178.5M · ER 0.29%5Y -1.7%
- BBP · Virtus Biotech ETFVirtus · $131.5M · ER 0.34%5Y 15.0%
- LFSC · F/M Emerald Life Sciences Innovation ETFEmerald Mutual Fund Advisers Trust · $123.4M · ER 0.54%
- IBBQ · Invesco Nasdaq Biotechnology ETFInvesco · $103.3M · ER 0.19%5Y 8.7%
- GNOM · Global X Genomics & Biotechnology ETFGlobal X Funds · $102.9M · ER 0.50%5Y -3.8%